Legal & General Group’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.53M | Buy |
364,530
+215,226
| +144% | +$2.89M | ﹤0.01% | 1549 |
|
|
2025
Q4 | $1.88M | Sell |
149,304
-14,988
| -9% | -$171K | ﹤0.01% | 1992 |
|
|
2025
Q3 | $1.64M | Buy |
164,292
+6,589
| +4% | +$59.1K | ﹤0.01% | 2060 |
|
|
2025
Q2 | $1.28M | Buy |
157,703
+5,238
| +3% | +$39.5K | ﹤0.01% | 2166 |
|
|
2025
Q1 | $1.28M | Buy |
152,465
+1,756
| +1% | +$14.7K | ﹤0.01% | 2090 |
|
|
2024
Q4 | $1.19M | Buy |
150,709
+20,068
| +15% | +$168K | ﹤0.01% | 2173 |
|
|
2024
Q3 | $1.09M | Buy |
130,641
+393
| +0.3% | +$3.07K | ﹤0.01% | 2205 |
|
|
2024
Q2 | $827K | Buy |
130,248
+14,823
| +13% | +$94.1K | ﹤0.01% | 2258 |
|
|
2024
Q1 | $699K | Buy |
115,425
+28,999
| +34% | +$164K | ﹤0.01% | 2311 |
|
|
2023
Q4 | $525K | Buy |
86,426
+76,124
| +739% | +$339K | ﹤0.01% | 2431 |
|
|
2023
Q3 | $43.5K | Sell |
10,302
-1,287
| -11% | -$4.8K | ﹤0.01% | 2883 |
|
|
2023
Q2 | $36K | Sell |
11,589
-9,404
| -45% | -$20K | ﹤0.01% | 2917 |
|
|
2023
Q1 | $29.2K | Sell |
20,993
-22,522
| -52% | -$44.8K | ﹤0.01% | 2970 |
|
|
2022
Q4 | $86.6K | Buy |
43,515
+3,557
| +9% | +$7.97K | ﹤0.01% | 2847 |
|
|
2022
Q3 | $81K | Buy |
39,958
+1,528
| +4% | +$4.28K | ﹤0.01% | 2874 |
|
|
2022
Q2 | $122K | Sell |
38,430
-591
| -2% | -$2.14K | ﹤0.01% | 2795 |
|
|
2022
Q1 | $163K | Sell |
39,021
-62,612
| -62% | -$277K | ﹤0.01% | 2734 |
|
|
2021
Q4 | $487K | Hold |
101,633
| – | – | ﹤0.01% | 2424 |
|
|
2021
Q3 | $543K | Buy |
101,633
+18,694
| +23% | +$94.1K | ﹤0.01% | 2392 |
|
|
2021
Q2 | $425K | Hold |
82,939
| – | – | ﹤0.01% | 2366 |
|
|
2021
Q1 | $559K | Buy |
82,939
+365
| +0.4% | +$2.02K | ﹤0.01% | 2286 |
|
|
2020
Q4 | $377K | Sell |
82,574
-216
| -0.3% | -$957 | ﹤0.01% | 2309 |
|
|
2020
Q3 | $322K | Sell |
82,790
-4,349
| -5% | -$18.6K | ﹤0.01% | 2281 |
|
|
2020
Q2 | $415K | Sell |
87,139
-2,181
| -2% | -$8.98K | ﹤0.01% | 2213 |
|
|
2020
Q1 | $310K | Buy |
89,320
+38,426
| +76% | +$163K | ﹤0.01% | 2189 |
|
|
2019
Q4 | $245K | Buy |
50,894
+8,739
| +21% | +$30.4K | ﹤0.01% | 2350 |
|
|
2019
Q3 | $122K | Buy |
42,155
+4,448
| +12% | +$15.5K | ﹤0.01% | 2466 |
|
|
2019
Q2 | $270K | Buy |
37,707
+2,816
| +8% | +$28.8K | ﹤0.01% | 2269 |
|
|
2019
Q1 | $495K | Buy |
34,891
+386
| +1% | +$5.1K | ﹤0.01% | 2153 |
|
|
2018
Q4 | $467K | Buy |
34,505
+1,810
| +6% | +$32.6K | ﹤0.01% | 2132 |
|
|
2018
Q3 | $726K | Buy |
32,695
+5,596
| +21% | +$118K | ﹤0.01% | 2037 |
|
|
2018
Q2 | $445K | Buy |
+27,099
| New | +$476K | ﹤0.01% | 2141 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
